Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

twig logo

twig emerges from stealth with £3m in funding, to create a new bioengineering powerhouse in the UK

20th September 2023

The new start-up will harness an AI-first approach to develop eco-friendly alternatives to everyday ingredients in consumer goods.
Halo-xray

HALO X-ray Secures Investment to Accelerate its Disruptive X-ray Diffraction Technology for Security Screening and Contraband Detection

12th September 2023

Investments in HALO X-ray Technologies will support regulatory approval of the first fieldable XRD system in checkpoint security…
Fusion

UKI2S tops £100 million to provide UK economic boost

30th August 2023

Investment in the UK Innovation & Science Seed Fund (UKI2S), a driving force in supporting early-stage innovation and high-impact businesses, now totals £102m
IFAST in the lab

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

17th February 2023

Bacterial resistance to antibiotics is growing as a critical worldwide challenge, often stated as the next potential pandemic.
Lab work

UKI2S 2022 year in review

15th December 2022

It’s been an exciting year for UKI2S, with £37 million additional capital into the fund, expansion of our role to include investments into Defence and Security and Fusion…
Iain Miller, CEO of PreSymptom Health

CEO Spotlight: Iain Miller, CEO of PreSymptom Health

6th December 2022

You develop an instinct through your career. Like an experienced driver, you start to see problems before they happen, you come to know that the car at the junction ahead might come out…
Oliver Sexton, Investment Director at UKI2S

What makes an exceptional start-up leader?

17th November 2022

Start ups may be founded by an individual with a grand vision but almost as soon as they raise the first pound a founder is joined by a nascent and fast growing team.

Solar power

The role of seed funding in net zero solutions

15th November 2022

Funding early-stage technology companies is critical for turning innovation and science into real world solutions, including those which will help us adapt to and combat climate change.
Tokamak Energy

Tokamak Energy announces ST80-HTS advanced prototype on path to demonstrate grid ready fusion power in the early 2030s

26th October 2022

Tokamak Energy today announces plans for its advanced prototype, ST80-HTS, which will be the world’s first high field spherical tokamak using high temperature superconducting…
Gary Owen, CEO of Lineat Composites

CEO Spotlight: Gary Owen, CEO of Lineat Composites

24th October 2022

As the world transitions towards hydrogen storage, there is increasing demand for storage vessels which are made from carbon fibre.

X-ray image

Silveray announces £2.2M seed round for ultra-efficient X-ray detector technology

12th October 2022

Surrey University spin-out company raises £1.5M in a seed round led by UKI2S to commercialise a novel nano-material that makes X-ray detectors more efficient and promises a more viable route to wide area detector panels.
lab work

NAMSA acquires UK-based Perfectus Biomed Group to enhance customised microbiological solutions

5th October 2022

NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group…
Dr Andrew Mackintosh

How public sector knowledge assets can contribute to economic growth

22nd September 2022

In April 2021, HM Treasury published a new report (‘Getting smarter: a strategy for knowledge & innovation assets in the public sector’) to support the effective management of public…
Artist impression Drax panamax with FastRigs

Smart Green Shipping announces £5m investment into FastRig wing sail technology

28th July 2022

Three-year project backed by the Scottish Government and industry will develop and test fully automated, emission-reduction sail technology that can be retrofitted to merchant ships.
oxford space

UKI2S expands fund by £37m to boost support of British innovation

25th July 2022

25, July 2022 – The UK Innovation and Science Seed Fund (“UKI2S”) today announced the expansion of its patient capital fund by £37m. UKI2S is an early-stage investment fund backed by UK Research and Innovation (UKRI), Defence Science and Technology Laboratory (Dstl), the Department of Business, Energy and Industrial Strategy (BEIS), the UK Atomic Energy…

Oxford Space Systems

UK space companies’ partnership completed the development of an advanced deployable SAR antenna payload

22nd July 2022

Oxford Space Systems (OSS) and Surrey Satellite Technology Ltd (SSTL) have completed the build of an innovative deployable Synthetic Aperture Radar (SAR) antenna payload for the next…
test tubes

CHAIN Biotech appoints new Chief Executive

20th July 2022

CHAIN announces the appointment of Dr Matthew Duchars as Chief Executive from the 1st of August 2022.
Jon Rees, CEO of MitoRx Therapeutics

CEO Spotlight: Jon Rees, CEO of MitoRx Therapeutics

20th July 2022

MitoRx is a preclinical research stage biotechnology company developing first-in-class, orally available, mitochondrial protective therapeutics targeting rare…
Human Microbiome

Nemesis Bioscience awarded €2m EIC accelerator grant

19th July 2022

Nemesis Bioscience Ltd announced today that it has been awarded a European Innovation Council (EIC) Accelerator grant of €2 million to advance its work in the prevention of antibiotic-resistant infections.
Mirico

Mirico accelerates climate change monitoring with investment led by Shell Ventures

18th July 2022

Mirico announced today that it had raised £2m to accelerate roll out of its greenhouse gas emissions monitoring solutions.

Dr Yoshinori Yamano

Nemesis bioscience announces the appointment of Dr Yoshinori Yamano as non-executive director

15th July 2022

Nemesis Bioscience Ltd announced today that it had appointed Dr Yoshinori Yamano to its board as a non-executive director.
Andy Muir, Alexander Leigh

Science Ventures Series: Valuation of start-ups as a seed investor

12th July 2022

We base our business model on the “power law” and estimate two out of ten early-stage investments will generate extraordinary financial return to cover the entire value of the fund.
test tubes

CHAIN Biotech and the University of Oxford collaborate to tackle oral vaccine inequality

15th June 2022

CHAIN announces a new collaboration with clinical researchers at the University of Oxford to develop superior oral vaccines for infectious diseases.
Richard Anderson

Science Venture Series: How can start-ups build a strong reputation?

7th June 2022

What is your most crucial piece of advice to founders and entrepreneurs building a reputation for their businesses?
Make brand building a core part of your strategy…
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, t/a Midven, c/o WeWork, 55 Colmore Row, Birmingham, B3 2AA.

Stay updated